255 related articles for article (PubMed ID: 30703198)
1. Patient Experience of Thyroid Cancer Active Surveillance in Japan.
Davies L; Roman BR; Fukushima M; Ito Y; Miyauchi A
JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):363-370. PubMed ID: 30703198
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Cancer Active Surveillance Program Retention and Adherence in Japan.
Davies L; Chang CH; Sirovich B; Tuttle RM; Fukushima M; Ito Y; Miyauchi A
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):77-84. PubMed ID: 33237264
[TBL] [Abstract][Full Text] [Related]
3. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
4. Experience of US Patients Who Self-identify as Having an Overdiagnosed Thyroid Cancer: A Qualitative Analysis.
Davies L; Hendrickson CD; Hanson GS
JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):663-669. PubMed ID: 28278335
[TBL] [Abstract][Full Text] [Related]
5. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
6. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
7. The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms.
Dixon PR; Tomlinson G; Pasternak JD; Mete O; Bell CM; Sawka AM; Goldstein DP; Urbach DR
JAMA Oncol; 2019 Jun; 5(6):817-823. PubMed ID: 30896738
[TBL] [Abstract][Full Text] [Related]
8. Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.
Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
Ann Surg; 2022 Jul; 276(1):e40-e47. PubMed ID: 33074908
[TBL] [Abstract][Full Text] [Related]
9. Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Zahedi A; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2024 May; 34(5):626-634. PubMed ID: 38481111
[No Abstract] [Full Text] [Related]
10. Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.
Ito Y; Miyauchi A; Kudo T; Oda H; Yamamoto M; Sasai H; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Miya A
Thyroid; 2018 Apr; 28(4):488-495. PubMed ID: 29608416
[TBL] [Abstract][Full Text] [Related]
11. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
[No Abstract] [Full Text] [Related]
13. NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.
Roman BR; Brito JP; Saucke MC; Lohia S; Jensen CB; Zaborek N; Jennings JL; Tuttle RM; Davies L; Pitt SC
Endocr Pract; 2021 Jan; 27(1):1-7. PubMed ID: 33471727
[TBL] [Abstract][Full Text] [Related]
14. The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.
Koo K; Zubkoff L; Sirovich BE; Goodney PP; Robertson DJ; Seigne JD; Schroeck FR
Urology; 2017 Oct; 108():122-128. PubMed ID: 28739405
[TBL] [Abstract][Full Text] [Related]
15. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer.
Sawka AM; Ghai S; Tomlinson G; Rotstein L; Gilbert R; Gullane P; Pasternak J; Brown D; de Almeida J; Irish J; Chepeha D; Higgins K; Monteiro E; Jones JM; Gafni A; Goldstein DP
BMJ Open; 2018 Apr; 8(4):e020298. PubMed ID: 29654030
[TBL] [Abstract][Full Text] [Related]
16. Cancer-related worry in Canadian thyroid cancer survivors.
Bresner L; Banach R; Rodin G; Thabane L; Ezzat S; Sawka AM
J Clin Endocrinol Metab; 2015 Mar; 100(3):977-85. PubMed ID: 25393643
[TBL] [Abstract][Full Text] [Related]
17. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
18. Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives.
Zhu P; Zhang Q; Wu Q; Shi G; Wang W; Xu H; Zhang L; Qian M; Hegarty J
Thyroid; 2023 Jul; 33(7):826-834. PubMed ID: 36719782
[No Abstract] [Full Text] [Related]
19. Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance.
Evron JM; Reyes-Gastelum D; Banerjee M; Scherer LD; Wallner LP; Hamilton AS; Ward KC; Hawley ST; Zikmund-Fisher BJ; Haymart MR
J Clin Oncol; 2019 Nov; 37(32):3042-3049. PubMed ID: 31573822
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
